November 4, 2012. The government-backed Biomedical Catalyst programme announced major funding for the ground-breaking Q-CANCER project which will integrate QuantuMDx Group’s rapid on-chip lab processes and develop the first sub-20 minute tumour profiler. When commercialized within the next 3 years, the device will have a dramatic impact on the rapid and accurate diagnosis and staging of cancer. Q-CANCER has the potential to ease the suffering and prolong the lives of the 12.7m newly diagnosed cancer sufferers, globally, by enabling surgeons to immediately remove most, if not all of the tumour and oncologists to prescribe the correct treatment regime according to the type of cancer developed.
The £2.8m project, with £1.4m awarded by the Biomedical Catalyst, will further develop QuantuMDx Group’s platform technology to build a low cost, fully integrated, sample-to-result benchtop device that will enable either histopathologists themselves or lab technicians, to perform multiplex genotyping and tumour staging and profiling, within minutes. They will also be able to use formalin fixed or fresh tissue samples, thus allowing for easy integration into standard practice.
The Project brings together the nanotechnology and chemistry expertise of Newcastle University with the specialist Oncology expertise and cancer networks of Leaders in Oncology Limited (London), the sample prep technology of Magna Parva Limited (Leicester) and the design and engineering expertise of The Technology Partnership (Cambridge).
Colette Whitfield started her integrated MPhil/PhD this month and will be working on developing some methods to produce long uniform sequences of DNA. We wish her the best with her initial studies and look forward to seeing her in the labs in the near future. She will be part based in the Medical School working with Professor Bernard Connolly but will be having her main home in the Chemical Nanoscience Laboratory, with Dr Eimer Tuite and Dr Andrew Pike
Mrs Mufida Abdualla won a prize for her research presentation at the School of Chemistry’s research days, 8th and 15th June. This year due to the large number of final year PhD students the school held two days of talks and Mufida gave a very clear and well presented talk on her work on ferrocenyl surfaces. This is a fine achievement and special congratualtions for your efforts in giving a prize winning talk in a second language!
Fariba and Samira attended the DNA sensors meeting in Jena, Germany May 10-12th.
They presented posters titled:
10th Sept – 18th Sept
I spent a week in Hong Kong visiting high schools to give presentations on my research into DNA nanotechnology and to encourage students to think about pursuing science and particulary chemistry at University.
On Friday 16th I gave a Public Lecture at Hong University, on “Chemistry of your Senses” which went down with a bang, or two!
I also visited Hong Kong University of Science and Technology to begin discussions for setting up an exchange programme for our students to spend a year on a research project as part of their degree programme.
Many thanks to all the ESF schools for hosting me, in particular the HE counsellors and Chemistry staff. Plans are to return at the end of January 2012, so I am looking forward to seeing you all again then.
Jennifer Hannant returned to Newcastle to sit her oral viva with Professor Iain Fairlamb, (York University, UK) and Dr. Andrew Benniston. She passed with minor corrections. Congratulations Dr. Hannant!
Her thesis will be published here in the near future.
John Jolliffe was awarded an 8 week vacation scholarship by the Nuffield Foundation to study the synthesis of water-soluble azido acridine based intercalators. He started in tha lab today, and hopes to develop an improved system for the assembly of nanomaterials along the DNA double helix.
Mandy Tsang was awarded an 8 week scholarship by the Welcome Trust to study the integration of azido peptides with conducting polymer coated surfaces and nanowires for potential medical sensing applications. She started in tha lab today, and will work alongside Fariba, to develop some work from a previous MChem project.